Tender detail
Biologics rebate agreements 2026 – Ranibizumab (15)
Summary
Techniker Krankenkasse (TK) seeks to conclude rebate agreements with suitable pharmaceutical companies for the active ingredient ranibizumab. The agreements use uniform terms, involve no individual negotiations and do not grant exclusivity. The contract period starts on 1 July 2026 and ends no later than 30 June 2027, with a maximum duration of 12 months.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.